Days post-wounding | Triglycerides (mg/dl) | Cholesterol (TC) (mg/dl) | LDL-C (mg/dl) | HDL-C (mg/dl) | vLDL-C (mg/dl) | LDL-C/HDL | TC/HDL-C |
---|---|---|---|---|---|---|---|
Non-wounded N | 48.46 ± 3.62c | 53.59 ± 3.67c | 20.76 ± 2.05d | 33.87 ± 1.24a | 9.70 ± 0.72c | 0.61 ± 0.44c | 1.61 ± 0.04d |
N (4 days) | 47.01 ± 3.35c | 56.89 ± 8.15c | 20.80 ± 2.71d | 33.74 ± 2.06a | 9.41 ± 0.67c | 0.65 ± 0.06c | 1.73 ± 0.07d |
N (8 days) | 62.91 ± 2.56c | 46.08 ± 4.87c | 17.45 ± 1.36d | 25.49 ± 3.62a | 12.58 ± 0.51c | 0.72 ± 0.06bc | 1.78 ± 0.05d |
WPN (4 days) | 65.19 ± 2.06c | 64.59 ± 4.61bc | 23.55 ± 1.74cd | 37.78 ± 5.71a | 13.04 ± 0.41c | 0.63 ± 0.09c | 1.79 ± 0.20d |
WPN (8 days) | 69.23 ± 9.05c | 57.04 ± 8.86c | 22.61 ± 1.53d | 31.84 ± 3.42a | 13.30 ± 1.81c | 0.76 ± 0.06bc | 1.75 ± 0.08d |
Non-wounded D | 87.08 ± 6.72bc | 85.89 ± 6.78ab | 38.80 ± 3.48a | 32.53 ± 0.96a | 17.26 ± 1.68bc | 1.25 ± 0.10a | 2.55 ± 0.13a |
D (4 days) | 160.59 ± 16.69ab | 85.59 ± 4.56ab | 38.19 ± 3.31ab | 39.43 ± 3.21a | 32.12 ± 3.34ab | 1.00 ± 0.12ab | 2.20 ± 0.11bc |
D (8 days) | 90.43 ± 3.27bc | 53.11 ± 5.28c | 18.98 ± 0.87d | 29.56 ± 4.59a | 18.32 ± 0.63bc | 0.64 ± 0.11c | 1.88 ± 0.09cd |
WPD (4 days) | 219.51 ± 64.57a | 88.05 ± 8.73a | 36.70 ± 3.06ab | 45.53 ± 1.76a | 43.91 ± 12.91a | 0.82 ± 0.12bc | 2.33 ± 0.16ab |
WPD (8 days) | 84.33 ±7.60bc | 53.75 ± 5.96c | 16.83 ± 2.13d | 32.69 ± 3.43a | 16.87 ± 1.52bc | 0.71 ± 0.10bc | 1.87 ± 0.12cd |
F-probability | p < 0.01 | p < 0.01 | p < 0.001 | p > 0.05 | p < 0.01 | p < 0.01 | p < 0.001 |
LSD at the 5% level | 7.68 | 22.67 | 8.41 | - | 15.34 | 0.32 | 0.34 |
LSD at the 1% level | 10.34 | 30.53 | 11.32 | - | 20.66 | 0.43 | 0.46 |